Literature DB >> 24796905

Techniques to reduce radiation and contrast volume during EVAR.

B Maurel1, A Hertault, J Sobocinski, M Le Roux, T Martin Gonzalez, R Azzaoui, M Saeed Kilani, M Midulla, S Haulon.   

Abstract

There is a large variability observed in the literature regarding radiation exposure and contrast volume injection during endovascular aortic repair (EVAR). Reducing both in order to decrease their respective toxicities must be a priority for the endovascular therapist. Radiation dose reduction requires a strict application of the "as low as reasonably achievable" principles. Firstly, all X-ray system settings should be defaulted to low dose, and fluoroscopic time reduced as much as possible. Digital subtraction angiography runs should be replaced by recorded fluoroscopy runs when possible. Magnification should be avoided, whereas collimation should be systematic to minimize scatter radiation and focus only on the area of interest. Advanced imaging modes can also contribute to dose reduction. For instance, image fusion can facilitate endovascular navigation, and allow table and C-arm positioning without fluoroscopy. In our experience, routine use of image fusion during EVAR significantly reduces both radiation exposure and contrast volumes during complex EVAR. To make these imaging modes useable in real life settings, the X-ray system should be fully controlled by the operator from table side. Reducing iodinated contrast volume, while maintaining image quality, can also be achieved through the use of automated contrast injectors. Additionally, alternative contrast agents, like carbon dioxide (CO2) and gadolinium, have also been evaluated and can be used in specific cases. Contrast-enhanced ultrasound and intravascular ultrasonography are currently developed as potential alternatives to both iodinated contrast use and X-ray during EVAR. Lastly, specific education and training of operators in radiation protection are essential.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24796905

Source DB:  PubMed          Journal:  J Cardiovasc Surg (Torino)        ISSN: 0021-9509            Impact factor:   1.888


  6 in total

1.  Radiation Exposure in Endovascular Infra-Renal Aortic Aneurysm Repair and Factors that Influence It.

Authors:  Rui Machado; Vitor Miguel Dias Ferreira; Luis Loureiro; João Gonçalves; Pedro Oliveira; Rui Almeida
Journal:  Braz J Cardiovasc Surg       Date:  2016 Nov-Dec

2.  Three-dimensional fusion computed tomography decreases radiation exposure, procedure time, and contrast use during fenestrated endovascular aortic repair.

Authors:  Michael M McNally; Salvatore T Scali; Robert J Feezor; Daniel Neal; Thomas S Huber; Adam W Beck
Journal:  J Vasc Surg       Date:  2014-08-28       Impact factor: 4.268

3.  Efficacy Analysis of a Script-based Guide for EVAR Execution: is it Possible to Reduce Patient Exposure to Contrast, Operative Time and Blood Loss even when Advanced Technologies are not Available?

Authors:  Giovani José Dal Poggetto Molinari; Ana Terezinha Guillaumon; Andréia Marques de Oliveira Dalbem
Journal:  Braz J Cardiovasc Surg       Date:  2015 Nov-Dec

4.  A perioperative strategy for abdominal aortic aneurysm in patients with chronic renal insufficiency.

Authors:  Makoto Haga; Katsuyuki Hoshina; Kunihiro Shigematsu; Toshiaki Watanabe
Journal:  Surg Today       Date:  2015-12-08       Impact factor: 2.549

5.  Experience With Fenestrated Endovascular Repair of Juxtarenal Abdominal Aortic Aneurysms at a Single Center.

Authors:  Zhongzhou Hu; Yue Li; Ran Peng; Jie Liu; Tao Zhang; Wei Guo
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

6.  Three-Dimensional Holographic Guidance, Navigation, and Control (3D-GNC) for Endograft Positioning in Porcine Aorta: Feasibility Comparison With 2-Dimensional X-Ray Fluoroscopy.

Authors:  Karl West; Sara Al-Nimer; Vikash R Goel; Jeffrey H Yanof; Aydan T Hanlon; Crew J Weunski; Jackie Kattar; Behzad S Farivar
Journal:  J Endovasc Ther       Date:  2021-06-18       Impact factor: 3.487

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.